Tools
Stock profile

Butterfly Network, Inc. (BFLY)

BFLY · Latest close $6.08 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$6.08
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
0
vs previous quarter

Butterfly Network, Inc. (BFLY) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $4.9M sold). Latest close $6.08 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 13, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-4.9M
Fundamentals
Revenue · FY2025
Red flags
screens flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Polen Capital Management — 1 tracked fund hold BFLY. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 10 sales ($4.9M). Insider trading

Often held alongside

GE HealthCare Technologies Inc. (GEHC) · KONINKLIJKE PHILIPS NV (PHG) · THERMO FISHER SCIENTIFIC INC. (TMO) · INTUITIVE SURGICAL INC (ISRG) · Medtronic plc (MDT) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Polen Capital Management0.03%480,502ADDED (+18.3%) Q3 filed Nov 13

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -27.5% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

9.930.992024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding247 of 8,857 filers
Long-only filers among them244
Change vs 2026 Q1+13 net · 238 entered · 225 exited
Shares reported, all filers158,338,195
Reported value, all filers$1.4B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryX-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
Revenue · FY2025$97.6M
Net income · FY2025$-77.1M
Total assets · FY2025$296.5M
Shares outstanding247,124,365
Market cap (at latest close)$1.5B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.

Short interest

Shares short · Oct 15, 202633,592,331
Share of shares outstanding13.59%
Days to cover6.19

Shares short at recent settlements — Jul 31, 2026: 32.7M · Aug 14, 2026: 32.2M · Aug 31, 2026: 34.1M · Sep 15, 2026: 35.7M · Sep 30, 2026: 31.6M · Oct 15, 2026: 33.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 672K · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 600 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 10 sales by 6 insiders ($4.9M).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 13, 2026ROTHBERG JONATHAN MSell359,382$6.20$2.2MSEC filing
Nov 11, 2026Doherty John N.EVP, CFOSell50,000$7.00$350.0KSEC filing
Oct 30, 2026DEVIVO JOSEPHPresident & CEOSell90,600$7.01$634.9KSEC filing
Oct 6, 2026DEVIVO JOSEPHPresident & CEOSell35,790$10.02$358.6KSEC filing
Oct 2, 2026Carlson MeganCAO and SVP, FinanceSell10,114$8.74$88.4KSEC filing
Sep 23, 2026DEVIVO JOSEPHPresident & CEOSell3,169$10.02$31.8KSEC filing
Sep 22, 2026DEVIVO JOSEPHPresident & CEOSell2,811$10.00$28.1KSEC filing
Sep 4, 2026Cashman SteveChief Business OfficerSell140,112$7.30$1.0MSEC filing
Sep 4, 2026Carlson MeganCAO and SVP, FinanceSell13,804$7.30$100.8KSEC filing
Sep 2, 2026Caezza NicholasDeputy General CounselSell1,709$8.15$13.9KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Oct 6, 2026DEVIVO JOSEPHOfficer, Director35,790$358.6KOct 6, 2026SEC filing
Oct 2, 2026Carlson MeganOfficer10,114$88.4KOct 2, 2026SEC filing
Sep 23, 2026DEVIVO JOSEPHOfficer, Director3,169$31.8KSep 23, 2026SEC filing
Sep 23, 2026Schwartz EricaFormer Director323,020$3.2MSep 23, 2026SEC filing
Sep 22, 2026DEVIVO JOSEPHOfficer, Director2,811$28.1KSep 22, 2026SEC filing
Sep 22, 2026Schwartz EricaFormer Director78,679$786.8KSep 22, 2026SEC filing
Sep 4, 2026Cashman SteveOfficer140,112$1.0MSep 4, 2026SEC filing
Sep 4, 2026Carlson MeganOfficer13,804$100.8KSep 4, 2026SEC filing
Sep 2, 2026Caezza NicholasOfficer1,709$13.9KSep 2, 2026SEC filing
Aug 11, 2026Caezza NicholasOfficer10,000$97.5KAug 11, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Aug 17, 2026SCHEDULE 13D/A-36.1% (close Aug 18, 2026 → Nov 17, 2026)

Reference close is the first trading day after the filing (Aug 18, 2026). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 17, 2026Rothberg Jonathan M.SC 13D/A828,7750.3%Aug 14, 2026SEC filing
Aug 17, 2026GLENVIEW CAPITAL MANAGEMENT, LLCSC 13D/A11,743,5304.8%Aug 13, 2026SEC filing
Aug 14, 2026Hood River Capital Management LLCSC 13G13,190,1305.6%Jun 30, 2026SEC filing
Aug 7, 2026FMR LLCSC 13G28,952,296.8911.8%Jul 31, 2026SEC filing
Jul 27, 2026BlackRock, Inc.SC 13G/A18,274,7867.8%Jun 30, 2026SEC filing
Jul 21, 2026Rothberg Jonathan M.SC 13D/A828,7750.4%Jul 21, 2026SEC filing
Jul 17, 2026Rothberg Jonathan M.SC 13D/A828,7750.4%Jul 15, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Mar 17, 2026Rothberg Jonathan M.SC 13D/A3,548,1591.6%Mar 13, 2026SEC filing
Feb 17, 2026GLENVIEW CAPITAL MANAGEMENT, LLCSC 13D/A14,335,0556.3%Feb 12, 2026SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 50 Lobbying Disclosure Act filings named this company as client, 2021–2026; most common issues: Health Issues (19), Science/Technology (16), Medical/Disease Research/Clinical Labs (8).

Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Red Flags

· Distress Risk (Altman Z″) — Altman Z″-Score below 1.10

Key figures

· Distress Risk (Altman Z″) — Z″-Score: -5.51 · Working capital / assets: 0.62 · Retained earnings / assets: -2.96 · EBIT / assets: -0.29 · Equity / liabilities: 1.95

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 2 of the last 20 quarterly lists; latest 2025 Q4, ranked #46 of 50.

Also held by the tracked funds that hold BFLY — ranked by lift, the co-holding pattern described in Methodology: GE HealthCare Technologies Inc. (GEHC) · KONINKLIJKE PHILIPS NV (PHG) · THERMO FISHER SCIENTIFIC INC. (TMO) · INTUITIVE SURGICAL INC (ISRG) · Medtronic plc (MDT) · WATERS CORP /DE/ (WAT) · BECTON DICKINSON & CO (BDX) · BOSTON SCIENTIFIC CORP (BSX).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Oct 29, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Oct 5, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and ExhibitsSEC filing
Aug 11, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

GE HealthCare Technologies Inc. (GEHC) · Track Record: how the signals scored · Practice timing on BFLY

One email a week: the week’s new filings and research. Subscribe free

← BFH  ·  BG →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.